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Abstract
Background: Alpha-tomatine (a-tomatine) is the major saponin in tomato (Lycopersicon esculentum). This study investigates
the chemopreventive potential of a-tomatine on androgen-independent human prostatic adenocarcinoma PC-3 cells.
Methodology/Principal Findings: Treatment of highly aggressive human prostate cancer PC-3 cells with a-tomatine
resulted in a concentration-dependent inhibition of cell growth with a half-maximal efficient concentration (EC50) value of
1.6760.3 mM. It is also less cytotoxic to normal human liver WRL-68 cells and normal human prostate RWPE-1 cells.
Assessment of real-time growth kinetics by cell impedance-based Real-Time Cell Analyzer (RTCA) showed that a-tomatine
exhibited its cytotoxic effects against PC-3 cells as early as an hour after treatment. The inhibitory effect of a-tomatine on
PC-3 cancer cell growth was mainly due to induction of apoptosis as evidenced by positive Annexin V staining and
decreased in mitochondrial membrane potential but increased in nuclear condensation, polarization of F-actin, cell
membrane permeability and cytochrome c expressions. Results also showed that a-tomatine induced activation of caspase-
3, -8 and -9, suggesting that both intrinsic and extrinsic apoptosis pathways are involved. Furthermore, nuclear factor-kappa
B (NF-kB) nuclear translocation was inhibited, which in turn resulted in significant decreased in NF-kB/p50 and NF-kB/p65 in
the nuclear fraction of the treated cells compared to the control untreated cells. These results provide further insights into
the molecular mechanism of the anti-proliferative actions of a-tomatine.
Conclusion/Significance: a-tomatine induces apoptosis and inhibits NF-kB activation on prostate cancer cells. These results
suggest that a-tomatine may be beneficial for protection against prostate cancer development and progression.
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Introduction
Prostate cancer is one of the leading causes of deaths in men
worldwide with major mortality due to advanced stage of the
cancer where androgen-independent cells become unresponsive to
hormone ablation therapy [1,2]. There is a pressing need to
identify alternative chemopreventive measures as surgery and
current chemotherapeutic strategies can be ineffective against the
aggressive form of prostate cancer [3–5].
Failure of cells to undergo apoptotic cell death contributes to the
development of cancers, hence treatment that induces apoptosis
would be a promising anticancer strategy [6,7]. Natural products are
important sources of new and less toxic anticancer agents. A variety of
dietary agents such as resveratrol, curcumin, sulforaphane, gingerol,
indole-3 carbinol, withanolide and green tea catechins can induce
apoptosis and are effective against various human cancer cells tested
[7–11]. These also have an added advantage of lesser toxicity
compared to current standard therapeutic drugs [12].
The present work investigates the chemopreventive potential of
alpha-tomatine (a-tomatine) against prostate cancer cells. a-
tomatine is the major saponin in tomato (Lycopersicon esculentum). It
possesses antimicrobial, antifungal, anti-inflammatory and immu-
nopotentiating activities [13–18]. It is protective against diben-
zo[a,l]pyrene (DBP)-induced liver and stomach tumors in rainbow
trout [19] and also promotes anti-proliferative effects against human
colon HT-29, liver HepG2, breast MCF-7 and stomach AGS
cancer cells [20,21]. Thus far, it is only known that a-tomatine acts
on phosphoinositide 3-kinase and protein kinase B (PI3K/Akt) and
extracellular signaling-regulating kinase (ERK) signaling pathways
in lung adenocarcinoma A549 cells [22]. The present study, hence,
seeks to investigate the effect of a-tomatine on the growth of human
prostatic adenocarcinoma PC-3 cells and to identify its potential
growth inhibitory mechanism. Results from the present study would
provide new insights into the beneficial role of a-tomatine for
prevention of prostate cancer development and progression.
Materials and Methods
Phytochemicals, standard drug and reagents
a-tomatine (purity.97%) was purchased from Extrasythese
(Genay, France). Paclitaxel from Ascent Scientific (Weston-
SuperMare, UK), a standard drug used in chemotherapy regimen
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for prostate cancer was used as positive control in this study.
Curcumin (Merck, Germany) was used as positive control in NF-
kB translocation assay. Dimethyl sulfoxide (DMSO) and tumor
necrosis factor-alpha (TNF-a) were purchased from Sigma Aldrich
(St. Louis, MO). Both the tested compound and positive controls
were prepared in 100% DMSO, stored at220uC, and then diluted
as needed in cell culture medium. Penicillin/streptomycin,
Dulbecco Modified Eagle Medium (DMEM), Roswell Park
Memorial Institute (RPMI 1640), keratinocyte growth medium,
fetal bovine serum (FBS) and MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenytetrazolium bromide) were purchased from Invitrogen
(Carlsbad, CA).
Cell lines
Prostate cancer PC-3 (CRL-1435), normal human liver WRL-
68 (CL-48) cells, and normal human prostate RWPE-1 (CRL-
11609) were obtained from the American Type Culture Collection
(Manassas, VA) and cultured in RPMI-1640, DMEM and
keratinocyte growth medium, respectively. Both RPMI-1640 and
DMEM were supplemented with 10% heat-inactivated FBS,
100 U/mL penicillin and 100 mg/mL streptomycin. Cells were
cultured at 37uC in a humidified atmosphere of carbon dioxide–
air (5:95).
In vitro cytotoxicity screening
Briefly, adherent cells were seeded in sterile 96-wells plates at
optimum cell density. After 18–24 hours, cells were treated with
increasing concentrations (0.16–5.0 mM) of a-tomatine for
24 hours. Cells treated with 0.2% DMSO was used as vehicle
control. Following treatment, cells were incubated in the dark with
2 mg/ml MTT at 37uC for 2 hours, then the medium was
carefully removed and 100 ml of DMSO was added to dissolve the
formazan crystals formed. Absorbance was measured at 570 nm in
a plate reader. Cell viability was calculated using the following
formula: (mean absorbance in test wells)/(mean absorbance in
control well)6100%. Dose-response curves were plotted using
GraphPad Prism 4 (GraphPad Software Inc., San Diego, CA).
Half maximal effective concentration (EC50) values were deter-
mined using non-linear regression model with sigmoidal dose
response (variable slope) following the algorithm of GraphPad
Prism 4.
Real time cell proliferation analysis
Real time growth kinetics of PC-3 cells was examined by
impedance-based Real-Time Cell Analysis (RTCA) system
(Roche Diagnostic, Mannheim, Germany). RTCA utilizes E-
plate which contains inter-digitated micro-electrodes on the
bottom of the plate that detect local ionic changes as cells
proliferate and is measured as electrode impedance. Briefly,
50 ml of medium was added in 16-wells E-plate and
background readings were recorded. Cell suspension (50 ml)
at cell density of 1.256104 cells/well was added to each well of
the E-plate. The attachment, spreading and proliferation of the
cells were monitored every 5 minutes intervals. When the cells
entered logarithmic growth phase, they were treated with
100 ml of a-tomatine at various concentrations and continu-
ously monitored every 10 minutes for up to 72 hours. Cells
treated with 0.2% of DMSO was used as vehicle control and
monitored in parallel with the a-tomatine and paclitaxel-
treated cells. Cell sensor impedance was expressed as an
arbitrary unit called the Cell Index (CI). The CI at each time
point was defined as (Rn2Rb)/15, where Rn is the cell-
electrode impedance of the well and the Rb is the background
impedance of the well with the media alone. Growth curves
were normalized to the CI at the last measured time point
before compound addition for each well.
Figure 1. The effect of a-tomatine on cell viability of PC-3, WRL-68 and RWPE-1 cells. Cells were treated with a-tomatine for 24 hours and
cell proliferation was measured using MTT reduction assay. Each value represents the mean 6 SD of three independent experiments, performed in
triplicates. EC50 values of a-tomatine on PC-3 cancer cell, WRL-68 normal cells and RWPE-1 normal prostate cells at 24 hours treatment were
1.6760.3 mM, .5.0 mM and 3.8560.1 mM, respectively.
doi:10.1371/journal.pone.0018915.g001
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Figure 2. Dynamic assessment of cell viability after treatment with a-tomatine. Normalized Cell Index (CI) measured over 72 hours on A)
prostate cancer PC-3, B) human normal liver WRL-68 and C) human normal prostate RWPE-1 cells. Briefly, cells at logarithmic growth phase were
treated with a-tomatine and CI values were recorded every 10 minutes intervals using RTCA MP system. Cells treated with 5.0 mM paclitaxel and 0.2%
DMSO were used as positive and negative controls, respectively. A change in impedance as the cells spread on the E-plate was displayed as CI value.
Plotted CI values were normalized to the last time point before addition of treatment.
doi:10.1371/journal.pone.0018915.g002
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Annexin V/propidium iodide (PI) double staining assay
Apoptosis-mediated cell death of tumor cell was examined by a
double staining method using FITC-labeled Annexin V/PI
apoptosis detection kit (BD Bioscience, San Jose, CA) according
to the manufacturer’s instructions. Briefly, control and a-tomatine-
treated cells were collected, washed in cold phosphate-buffered
saline (PBS) twice, stained with fluoresceinisothiocyanate (FITC)-
conjugated Annexin V and PI dyes. The externalization of
phoshotidylserine and the permeability to PI were evaluated by
FACS Calibur flowcytometer (BD Bioscience, San Jose, CA). Data
from 10,000 gated events per sample were collected. Cells in early
stages of apoptosis were positively stained with Annexin V;
whereas, cells in late apoptosis were positively stained with both
Annexin V and PI.
Multiparametric High Content Screening (HCS) assays
HCS (Cellomics Inc, Pittsburgh, PA, USA) enables concurrent
quantitative measurement of multiple independent cellular
phenotypes using fluorescent probes. Both Cellomics multipara-
metric cytotoxicity and apoptosis HitKitTM (Pittsburgh, PA, USA)
were used to examine cellular changes in the a-tomatine-treated
PC-3 cells. Multiparametric cytotoxicity HitKitTM contains four
fluorescent dyes, i.e. blue fluorescent Hoechst 33342, membrane
permeability, mitochondrial membrane potential, and cytochrome
c dyes. They respectively detect changes in nuclear morphology
(nuclear condensation), membrane permeability, mitochondrial
membrane potential and expression of cytochrome c. The
multiparametric apoptosis kit quantifies three fundamental
parameters related to the process of apoptosis, i.e. (i) nuclear
condensation, detected by the blue fluorescent nuclear dye,
Hoechst 33342; (ii) F-actin content, detected by green fluorescent
Alexa Fluor H 488Phalloidin stain; (iii) mitochondrial membrane
potential, based on the uptake of MitoTracker H Red into
mitochondria of cells. Briefly, PC-3 cells were seeded overnight at
density of 8000 cells/well into flat-bottomed 96-well plates (Perkin-
Elmer Inc., Wellesley, MA, USA). Following treatment with
different concentrations of a-tomatine (0.25 to 2.0 mM), fixation
and staining for imaging analysis of the PC-3 cells were performed
according to the manufacturer’s instructions. Cells treated with
0.2% DMSO and 5.0 mM paclitaxel were used as negative and
positive controls, respectively. Plates were analyzed using Thermo
Scientific ArrayScanHVTI HCS Reader (Cellomics Inc, Pitts-
burgh, PA, USA). This is a computerized automated fluorescence
imaging microscope that automatically identifies stained cells and
measures the intensity and distribution of fluorescence in
individual cells. Images for each fluoroprobe were acquired at
different channels using suitable filters with 206objective at fixed
exposure time. The Cell Health Profiling BioApplication software
Figure 3. Annexin V/PI double staining assay. Cells were exposed to either 0.2% DMSO (vehicle control), 5.0 mM paclitaxel (positive control), or
a-tomatine for the indicated time. The treated cells were stained with Annexin V and PI and then subjected to FACS analysis. The percentages of early
apoptotic cells (Annexin V positive, PI negative) and late apoptotic cells (Annexin V and PI positive) observed at different incubation time with a-
tomatine are shown. Results are presented as the mean6 SD of three independent experiments. * P,0.05, ** P,0.01, *** P,0.001 vs vehicle control.
doi:10.1371/journal.pone.0018915.g003
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was used for image acquisitions and analysis. For each well, at least
25 fields, corresponding to at least 500 cells were automatically
acquired and analyzed. All experiments were performed in
triplicates. Cell average intensity (Mean) under the modified
object mask within selected range in each channel was used as
assay indicator, and reported as average fluorescence intensity.
Cell cycle phase distribution of a-tomatine-treated cells was
determined using Cellomics Cell Cycle BioApplication as
Figure 4. HCS analysis of apoptosis associated cellular morphology on a-tomatine-treated PC-3 cells. PC-3 cells were treated with
different concentrations of a-tomatine (0.5–2.0 mM). Cell morphology changes associated with apoptosis such as A) percentage of dead cells, B)
alterations in nuclear condensation, C) membrane permeability, D) mitochondrial membrane potential, E) expression of cytochrome c and F) F-actin
contents are reflected by the average fluorescence intensity detected. Cells treated with 0.2% DMSO and 5.0 mM paclitaxel were used as negative and
positive controls, respectively. All measured parameters were expressed as average fluorescent intensities and averaged for at least 500 cells per well.
Data is representative of three independent experiments.* P,0.05, ** P,0.01, *** P,0.001 vs vehicle control.
doi:10.1371/journal.pone.0018915.g004
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described previously [23]. It applies similar principles as FACS in
assessing cell cycle distribution where the intensity of Hoechst
stained nucleus is deemed proportional to the cell’s DNA content.
Total fluorescence intensity of the dye from the nucleus of each
cell typically exhibits a bimodal distribution. The first peak
typically contains cells with 2N DNA content (G0/G1 phase), the
second peak with a double intensity of the first, contains cells with
4N DNA content (G2/M phase). Under normal conditions, there
are more cells in the G0/G1 versus the G2/M phase. The region
between these two peaks represents cells with DNA content
between 2N and 4N (S phase) which are cells in the process of
doubling their DNA. Cells found with DNA,2N distribution are
usually apoptotic cells. To identify the range of each of the DNA
content categories, the software first identifies 2N (G0/G1 phase)
and 4N (G2/M phase) DNA content peaks using vehicle control
cells. Then, it automatically classified each cell’s nuclear total
intensity into one of the categories of DNA content: sub G1
(DNA,2N), G0/G1 (DNA,2N), S (2N,DNA.4N) and G2/M
(DNA,4N) phases in a-tomatine-treated cells. The percentage of
each cell cycle phase for vehicle control, paclitaxel-treated cells
and a-tomatine-treated cells were then reported.
Caspase activity
The activities of caspase-3, -8 and -9 were measured using the
fluorometric assay kit (Calbiochem, USA) following the protocol of
the manufacturer. Briefly, cells were treated with a-tomatine
(2.0 mM) with or without inhibitors (caspase-8: z-IETD-FMK;
caspase-9: z-LEHD-FMK; caspase-3-like: DEVD-CHO). After
treatment, the cells were harvested using trypsinization and cell
lysates were prepared as described [24]. The cell lysates were
mixed with reaction buffer and 10 ml of fluorogenic peptide
substrate: Ac-DEVD-AMC (caspase-3), Ac-IETD-AMC (caspase-
8) and Ac-LEHD-AMC (caspase-9), and incubated for 2 hours at
37uC in the dark. Inhibitors were added 30 minutes before
addition of fluorogenic substrate. Wells containing 50 ml of sample
buffer, 50 ml of assay buffer and 10 ml of substrate were used as
blank. Purified caspase was used as positive control while
untreated cell extract was used as negative control. Fluorescence
was then measured at excitation of 390 nm and emission of
500 nm. Fold-increase in the protease activity was determined by
comparing the levels of the treated cells with untreated controls.
NF-kB translocation assay
NF-kB translocation in PC-3 cells was examined using NF-kB
activation HCS kit which contains Hoechst 33342 and Alexa
Fluor 488 conjugated anti-NF-kB dyes. PC-3 cells were seeded
into sterile flat-bottomed 96-well plates (Perkin-Elmer Inc.,
Wellesley, MA, USA) at 8000 cells/well (100 ml/well). After 18–
24 hours, cells were treated with different concentrations of a-
tomatine for 30 minutes, followed by treatment with 10 ng/ml
Figure 5. Cytotoxic and proapoptotic effects of a-tomatine on PC-3 cells. PC-3 cells were treated for 24 hours with A) 0.2% DMSO, B) 5.0 mM
paclitaxel, and C) 2.0 mM a-tomatine. The treated cells were examined for nuclear condensation using blue Hoechst 33342 stain, changes in
membrane permeability using a green fluoroprobe, mitochondrial membrane potential using MitoTracker Red CMXRos dye, and cytochrome c
expression using a blue green fluoroprobe. Scale bar indicates 20 mm.
doi:10.1371/journal.pone.0018915.g005
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TNF-a for another 30 minutes. Cells pre-treated with 0.2%
DMSO and 50 mM curcumin were used as negative and positive
inhibitor controls, respectively. Fixation, permeabilization and
immunofluorescence staining of cells were performed according to
the manufacturer’s instructions. For target translocation analysis,
cells stained with Hoechst dye were identified as objects in channel
1 and an adjustable mask called Circ was created around every
nucleus. In non-activated cells, Alexa Fluor 488-stained NF-kB
was detected in channel 2 in the cytoplasm where an annular
region called Ring was defined beyond the nuclear region. Images
were acquired using suitable filters with 206 objective at fixed
exposure times. For each well, at least 500 cells were automatically
acquired and analyzed. The output feature MEAN_CircRingAv-
gIntenDiffCh2 represents the difference between the intensity of
nuclear and cytoplasmic NF-kB associated fluorescence (Nuc-Cyto
Diff), reported as translocation parameter, as previously described
[25].
NF-kB/p50 and NF-kB/p65 transcription factor assay
PC-3 cells at 70–80% confluence were treated with a-
tomatine for 30 minutes, followed by treatment with TNF-a
(10 ng/ml) for another 30 minutes. The cells were then washed
with PBS and the both nuclear and cytoplasmic fractions of the
treated cells were extracted using nuclear extraction kit
(Cayman Chemical, Ann Arbour, MI). Concentrations of the
active forms of NF-kB/p50 and NF-kB/p65 in the both
Figure 6. Cell cycle distribution of a-tomatine-treated PC-3 cells. The percentage of a-tomatine-treated cells at A) Sub G1, B) G0/G1, C) S, and
D) G2/M phases of PC-3 cells. Each bar represents the mean 6 SD of data from three independent experiments.* P,0.05, ** P,0.01, *** P,0.001 vs
vehicle control.
doi:10.1371/journal.pone.0018915.g006
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fractions were measured using Cayman NF-kB/p50 and NF-
kB/p65 ELISA kits (Ann Arbour, MI) according to the
instructions of the manufacturer. The differences in NF-kB/
p50 and NF-kB/p65 levels between the nuclear and cytoplasmic
fractions were reported.
Statistical analysis
All assays were conducted in at least three separate experiments.
Results are expressed as the mean value 6 standard deviation
(SD). Statistical analysis was performed with one-way analysis of
variance (ANOVA), with Dunnett’s Multiple Comparison Test to
identify between-group differences using GraphPad Prism soft-
ware (version 4.0; GraphPad Software Inc., San Diego, CA).
Statistical significant is expressed as ***, p,0.001; **, p,0.01; *,
p,0.05. Log EC50 calculations were performed using the built-in
algorithms from dose-response curves with variable slope.
Results
a-tomatine dose-dependently inhibited proliferation of
PC-3 cancer cells
To evaluate the effect of a-tomatine on cell viability of PC-3,
WRL-68 and RWPE-1 cells, MTT assay was performed.
Treatment of a-tomatine to PC-3 cells resulted in a significant
dose-dependent (from 0.16 to 5.0 mM) inhibition of cell growth
(Figure 1). The EC50 value at 24 hours post-treatment with a-
tomatine for PC-3 cells was estimated at 1.6760.3 mM. a-
tomatine only caused cytotoxicity towards normal prostate
RWPE-1 cells at highest concentration (5.0 mM) of a-tomatine,
with EC50 value of 3.8560.1 mM. Normal human liver WRL-68
cells treated with the highest concentration of a-tomatine tested
(5.0 mM) resulted in ,35% of nonviable cells and this suggest that
a-tomatine is less cytotoxic against WRL-68 cells when compared
to PC3 cells. The EC50 values of a-tomatine towards WRL-68
cells (.5 mM) and RWPE-1 (3.8560.1 mM) and were higher than
that of PC-3 cells (1.6760.3 mM), suggesting the selective
cytotoxicity of a-tomatine towards prostate cancer PC-3 cells.
Real-time growth kinetics analysis of a-tomatine using
cell impedance-based analyzer
The dynamics of PC-3 cells proliferation on the 16-wells E-
plates were monitored at every 5 minutes interval from the time of
plating until the cells entered the logarithmic growth phase,
following which the cells were treated with different concentrations
of a-tomatine. After treatment, CI values were acquired at every
10 minutes interval for 72 hours. It was observed that a rapid
decrease in CI value occurred as early as an hour after treatment
with 5.0 mM and 2.5 mM of a-tomatine on PC-3 cells (Figure 2A),
suggesting that PC-3 cells were dying from the treatment with
these concentrations. PC-3 cells treated at lower concentrations
(0.16–1.25 mM) of a-tomatine were proliferating in parallel to cells
treated with vehicle control as indicated with increase in CI values.
In contrast, WRL-68 cells treatment with a-tomatine showed no
reduction in CI values even at the highest tested concentration of
5.0 mM compared to control levels and it exhibited a continuous
rise in CI values throughout the 72 hours of treatment (Figure 2B).
This showed that WRL-68 cells growth was not affected by a-
tomatine. Treatment with 2.5 mM a-tomatine initially inhibited
normal prostate RWPE-1 cell proliferation but eventually
recovered to the level of vehicle control cells (Figure 2C).
Treatment with higher concentration (5.0 mM), however, de-
creased the CI values suggesting that a-tomatine inhibited the
proliferation of RWPE-1 cells at high concentration (Figure 2C).
These data suggested that a-tomatine at low concentration
(2.5 mM) can inhibit the growth of PC-3 prostate cancer cells
but not the normal prostate RWPE-1.
a-tomatine induces apoptosis on PC-3 cancer cells
To determine if a-tomatine induces apoptosis in PC-3
prostate cancer cells, Annexin V/propidium iodide (PI) double
staining assay and flow cytometry analysis were performed.
Treatment with 2.0 mM a-tomatine for 1, 3, 6 and 24 hours
resulted in a gradual increase in early apoptotic cells (Annexin
V positive only) from 2.0760.12% to 5.0060.97%,
14.5761.55%, and 21.5062.48%, respectively (Figure 3, black
bars). The late apoptotic cells (Annexin V and PI positive) were
also increased significantly, from 2.6360.56% to 4.0060.93%,
6.9361.3%, and 16.961.92% (Figure 3, white bars). Positive
control cells treated with 5.0 mM paclitaxel for 24 hours also
resulted in 7.1360.75% of early apoptotic cells (Figure 3, black
bars) and 21.5361.74% of late apoptotic cells (Figure 3, white
bars) in the culture compared with only 0.2360.09% of early
apoptotic cells (Figure 3, black bars) and 0.3760.12% of late
apoptotic cells (Figure 3, white bars) in the negative control
cells treated with 0.2% DMSO. Hence, these results showed
that a-tomatine inhibited PC-3 cells growth by inducing
apoptosis in these cells.
Multiparametric HCS assays
To further confirm the induction of apoptosis by a-tomatine, the
treated cells were examined for cellular changes associated with
apoptosis using HCS analysis. Treatment with 2.0, 1.0 and 0.5 mM
a-tomatine resulted in approximately 95%, 83% and 20% cell loss,
respectively (Figure 4A). In comparison, positive control cells treated
with 5.0 mM paclitaxel resulted in only 45% cell loss and none from
the vehicle control cells (Figure 4A). The a-tomatine treated cells
also exhibited a concentration-dependent increase in nuclear
chromatin staining with Hoechst 33342 (Figures 4B and 5C),
suggesting an increase in nuclear condensation. Increased in nuclear
chromatin staining with Hoechst 33342 was also observed in the
paclitaxel positive control cells (Figure 4B and 5B) whereas the
fluorescent intensity was significantly lower and healthy nuclear
morphology was observed in the vehicle control cells (Figures 4B
and 5A). Membrane permeability of the treated cells also increased
significantly as evidenced by high fluorescent intensity in the
cytoplasm of a-tomatine (Figure 4C and 5C) and paclitaxel- treated
cells (Figure 4C, and 5B) compared to the vehicle control
(Figures 4C and 5A). A reduction in mitochondrial membrane
potential is observed in both paclitaxel (Figure 4D and 5B) and a-
tomatine (Figure 4D and 5C) treated cells compared to intact
mitochondrial membrane potential of the vehicle control cells
(Figure 4D and 5A). More specific apoptosis indicators such as
release of cytochrome c and F-actin polarization or cleavage were
found increased in a concentration-dependent manner in the
Figure 7. Effect of a-tomatine on caspases activation. Fold increase of the levels of A) caspase-3, B) caspase-8, and C) caspase-9 in PC-3 cells
treated with 2.0 mM a-tomatine, compared to vehicle control. The caspase activities were determined in the presence or absence of specific inhibitors
in time course manner. The fluorescence intensity was measured at excitation wavelength of 390 nm and emission wavelength of 500 nm. The
increase of protease activities was determined by comparing the levels in a-tomatine-treated PC-3 cells with the vehicle control. Each bar represents
the mean 6 SD of data from three independent experiments.* P,0.05, ** P,0.01, *** P,0.001 vs vehicle control.
doi:10.1371/journal.pone.0018915.g007
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cytoplasm of PC-3 treated cells, with the highest increase observed
at 2.0 mM a-tomatine (Figure 4E, 4F and 5C). These results further
confirmed that a-tomatine inhibited PC-3 cell growth by inducing
apoptosis.
a-tomatine-induced apoptosis in PC-3 cells is not
associated with cell cycle arrest
To determine whether induction of apoptosis in PC-3 cells by a-
tomatine could be related to the cell cycle arrest, cell cycle
distribution of the treated cells was assessed by labelling the cell’s
DNA with blue fluorescent Hoechst 33342 stain, whose intensity is
proportional to the cell’s DNA content. The sub G1 population
representing apoptotic cells in the 2.0 mM a-tomatine treated cells
was markedly increased (95%) compared to positive control cells
treated with paclitaxel (40%, Figure 6A). This increase was
reflected by significant reduction in cells at G0/G1 (Figure 6B), S
(Figure 6C), and G2/M phases (Figure 6D). No significant changes
in the percentage of population of cells in other phases were
observed in 0.5 and 1.0 mM treated cells, suggesting that induction
of apoptosis was not mediated by cell cycle arrest.
a-tomatine induced caspases activation
Caspases are present in the proforms (inactive) and become
active after site-specific cleavage to participate in the process of
apoptosis. To determine whether caspases are involved in
apoptosis induction by a-tomatine, the protein levels of active
caspases in a-tomatine-treated cells were evaluated. Activation of
the executioner procaspase-3 by a-tomatine was found to be
time-dependent (Figure 7A). Caspase-3 activity was significantly
elevated at the first hour of treatment and progressed to a
maximal level (6-fold over vesicle control) after 24 hours of
incubation (Figure 7A). High levels of pro-caspase-8 and pro-
caspase 9 were detected as early as 1 hour after the addition of
a-tomatine, and reached a maximal level at 6 hours of
incubation where the high levels of caspase 8 and 9 persisted
over 24 hours of incubation (Figure 7B and 7C). These findings
suggest that a-tomatine activated caspase-3, caspase-8 and
caspase-9 as early as 1 hour after treatment. Cell permeable-
specific inhibitors of caspase-3-like (DEVD-CHO, Figure 7A),
caspase-8 (z-IETD-FMK, Figure 7B) and caspase-9 (z-LEHD-
FMK, Figure 7C) were added into a-tomatine treatment to
determine whether the activation of caspase-3, -8 and -9 by a-
tomatine can be blocked by these inhibitors. In the presence of
inhibitors, fold increase of caspase-3 (Figure 7A), caspase-8
(Figure 7B) and caspase-9 (Figure 7C) were reduced. These
results further confirmed the activation of caspase-3, -8 and -9 by
a-tomatine in PC-3 cells.
a-tomatine inhibits TNF-a-induced NF-kB nuclear
translocation
It has been shown that activation of NF-kB blocks apoptosis and
promotes cell proliferation [26]. We assessed whether a-tomatine
inhibits activation of NF-kB induced by the inflammatory cytokine,
TNF-a using Alexa Fluor 488-conjugated anti-NF-kB antibody. In
cells treated with medium only (Figure 8A and 8Bii), high fluorescent
intensity of NF-kB was found in cytoplasm but dimly in nuclei,
indicating that NF-kB was not activated under resting condition.
Following stimulation with TNF-a alone, NF-kB fluorescent intensity
significantly increased in nuclei, suggesting that TNF-a stimulation
resulted in NF-kB activation and translocation from cytoplasm into
nuclei occurred in the stimulated cells (Figure 8A and 8Bi). However,
in PC-3 cells treated with curcumin, a known inhibitor of NF-kB
activation, it was observed that significant inhibition of TNF-a-
induced NF-kB nuclear translocation as evidenced by low nuclear
NF-kB-related fluorescence intensity (Figure 8A). Similarly, a-
tomatine also inhibited TNF-a-induced NF-kB activation in a
dose-dependent manner with strong inhibition observed at 2.0 mM
treatment (Figure 8A, and 8Biii). These results showed that a-
tomatine inhibit NF-kB activation.
a-tomatine treatment inhibited NF-kB/p50 and NF-kB/
p65 nuclear translocation
To further confirm TNF-a-induced NF-kB activation was
inhibited in a-tomatine treated PC-3 cells through the inhibition of
NF-kB nuclear translocation, NF-kB/p50 (Figure 9A) and NF-
kB/p65 (Figure 9B) in nuclear and cytoplasmic fractions of the
treated cells were measured by ELISA. Pretreatment with 2.0 mM
of a-tomatine resulted in significant decreased in both NF-kB/p50
(Figure 9A) and NF-kB/p65 (Figure 9B) level in nuclear fractions,
compared to cells treated with TNF-a control (Figure 9A and 9B).
These results showed that a-tomatine inhibits TNF-a-induced NF-
kB activation by inhibiting nuclear translocation of NF-kB/p50
and NF-kB/p65 in the treated PC-3 cells.
Discussion
a-tomatine was reported to inhibit growth of human colon HT-
29, liver HepG2, breast MCF-7 and stomach AGS cancer cells
[20,21] but its anti-proliferative mechanisms require further
definition. The present study reports that a-tomatine inhibits
NF-kB activation and induces apoptosis on androgen-independent
human prostatic adenocarcinoma PC-3 cells. The EC50 of a-
tomatine towards PC-3 cells was estimated at 1.6760.3 mM and
this value is comparable to earlier studies on different cancer cell
lines [20,21]. Dynamic assessment by xCelligence system showed
that a-tomatine is a fast-acting compound, inhibiting the cancer
cells proliferation as early as an hour after treatment with 2.5 and
5.0 mM a-tomatine and its growth suppressive effect was not fully
reversible as the cancer cell proliferation failed to recover
throughout 72 hours of treatment. It is also less cytotoxic against
human liver normal cells and human prostate normal cells.
Although our data showed that a-tomatine inhibited the growth of
normal prostate RWPE-1 cells at high concentration (5.0 mM),
where utilization of high dose of a-tomatine can be a key
consideration for cancer treatment, earlier in vivo studies showed
no apparent toxic effects in rainbow trout [19] and does not affect
body and liver weights of mice [14,27].
Figure 8. The inhibitory effect of a-tomatine on TNF-a-induced NF-kB nuclear translocation. PC-3 cells were pretreated with a-tomatine
for 30 minutes and followed by 10 ng/ml of TNF-a stimulation for 30 minutes. A) Cells treated with 50 mM curcumin and medium only were used as
positive NF-kB inhibitor and negative control, respectively. Cells were fixed, immunostained with anti-NF-kB antibody, and counterstained with
Hoechst 33342. NF-kB nuclear translocation index was measured using Thermo Scientific ArrayScanHVTI HCS Reader and expressed as the difference
between nuclear and cytoplasmic NF-kB related fluorescence intensity. Each bar represents the mean 6 SD of data in triplicate.* P,0.05, ** P,0.01,
*** P,0.001 vs cells treated withTNF-a alone. B) Images of PC-3 cells treated with 10 ng/mL TNF-a alone (i), medium only (ii), and 2.0 mM of a-
tomatine pretreatment before 10 ng/ml TNF-a stimulation (iii). Control and treated PC-3 cells were stained with Hoechst (blue) and the Alexa Fluor
488-conjugated anti-NF-kB antibody (green). Images were acquired for each fluorescence channel, using suitable filters with 206objective. Scale bar
indicates 20 mm.
doi:10.1371/journal.pone.0018915.g008
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Flow cytometry analysis of Annexin V/PI staining showed that
a-tomatine conspicuously induced apoptosis. This observation was
confirmed by multiparametric cell-based high content screening
(HCS) analysis that showed morphological features characteristic
of apoptotic cell death such as nuclear condensation, loss of
membrane symmetry, polarization of F-actin, release of cyto-
chrome c and reduction in mitochondrial membrane potential.
Disruption of the mitochondrial membrane potential is an early
event in apoptosis and triggers release of cytochrome c and other
apoptogenic molecules from the mitochondria to the cytosol [28].
Figure 9. Comparison of NF-kB/p50 and NF-kB/p65 protein levels between nuclear and cytoplasmic fraction. PC-3 cells were treated
with 0.5, 1.0, 2.0 mM a-tomatine for 30 minutes, followed by treatment with 10 ng/ml TNF-a for another 30 minutes. Nuclear and cytoplasmic
fractions of the PC-3 treated cells were extracted, the concentration of the active form of A) NF-kB/p50 and B) NF-kB/p65 in both fractions were
measured with ELISA kits. Differences of NF-kB/p50, NF-kB/p65 in the nuclear and cytoplasmic fractions are reported. Each bar represents the mean
6 SD of data in triplicate.* P,0.05, ** P,0.01, *** P,0.001 vs cells treated with TNF-a control.
doi:10.1371/journal.pone.0018915.g009
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These apoptogenic molecules contribute to the activation of
caspases and subsequent cell death. More intensive molecular
studies indicate that apoptotic cell death can be triggered either
through receptor (extrinsic)-mediated pathway where the ligand-
receptor binding activates caspase-8 or the mitochondrial
(intrinsic)-mediated pathway where cytochrome c is released from
the mitochondrial and activates caspase-9 [29,30]. Both of these
mechanisms will eventually merge and lead to the hierarchical
activation of the downstream caspase-3, 6 and 7, which are
responsible for the characteristic apoptosis-associated morpholog-
ical changes such as chromatin condensation, membrane bleb-
bing, and loss of overall cell shape [31,32]. The present study
demonstrated that treatment with a-tomatine increased activities
of caspase-3 and -9 and caused depolarization of mitochondrial
membrane potential and release of cytochrome c. These results
suggest that induction of apoptosis is mediated through the
intrinsic pathway. Pro-caspase-8 is an intracellular component that
directly communicates with the death domain of cell membrane
receptors and its activation in the a-tomatine-treated cells suggests
that apoptosis is also mediated through the extrinsic pathway
which perhaps merged with the intrinsic pathway and activated
the executioner caspase 3. Consistent with these data, addition of
cell permeable-specific inhibitors of caspase-8 (z-IETD-FMK),
caspase-9 (z-LEHD-FMK), or caspase-3-like (DEVD-CHO)
enzymes revealed that addition of caspase inhibitors completely
decreased a-tomatine-induced activation of caspase-3, -8 and -9,
confirmed the role of caspase-3, -8 and -9 in a-tomatine-induced
apoptosis. Curcumin is an example of dietary agent that mediates
apoptosis via both intrinsic and extrinsic pathways [33].
a-tomatine could also significantly alter polymerization of actin
filaments in the treated PC-3 cells. This observation is in line with
reports that showed polymerization or cleavage of actin cytoskel-
eton during the early and late phases of apoptosis [34–37].
Cisplatin, a well-known anticancer drug is an example of drug that
induces F-actin damage prior to changes in nuclear morphology
[38].
While the present study found no evidence of cell cycle arrest by
a-tomatine, there are evidence that suggest induction of apoptosis
could be mediated through the inhibition of nuclear factor-kappa
B (NF-kB) signaling pathway. Constitutive NF-kB activation has
been observed in many types of cancer, including androgen-
independent prostate cancer [26]. Overexpression of NF-kB/p65
protein was found in the nuclear fraction of prostate cancer clinical
specimens [39,40], suggesting the pathophysiological role for NF-
kB in prostate cancer progression. Constitutive activation of NF-
kB in tumor cells could promote cancer cells survival by blocking
apoptosis and promote cancer cells growth through angiogenesis,
metastasis and invasion [41]. Accumulating evidence indicate that
constitutive activation of NF-kB in tumor cells always contribute
to chemoresistance and radioresistance, and represents an
independent risk factor for recurrence after radical prostatectomy
[40,42,43]. Hence, targeting the NF-kB signaling pathway
remains an attractive therapeutic option for prostate cancer.
Treatment of PC-3 cells with a-tomatine resulted in a strong
inhibition of NF-kB activation, which was consistent with a
decrease in nuclear levels of NF-kB/p65 and NF-kB/p50. The
ability of a-tomatine in inhibiting NF-kB activation by blocking
the nuclear translocation of NF-kB/p65 and NF-kB/p50
transcription factors suggests its promising role in prostate cancer
prevention. Inhibition of NF-kB activation could indirectly
contribute to the pro-apoptotic action of a-tomatine on PC-3
cells as NF-kB controls the transcription of anti-apoptotic and cell
proliferation genes, essential for the survival of cancer cells [44].
In summary, these results show that a-tomatine has good
potentials as dietary phytochemical with pro-apoptosis activity. a-
tomatine can be further explored for its therapeutic potential in
the treatment of cancers where constitutive activation of NF-kB
and apoptosis resistance remain a major concern in cancer
chemotherapy. To establish the relevance of in vitro findings,
further study is underway to investigate in vivo anti-tumor and NF-
kB activities of a-tomatine using prostate xenograft cancer model.
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